Literature DB >> 2640221

[The macula in Adamantiades-Behçet disease].

G Palimeris1, G Theodossiades, B Constantinidou, E Chimonidou.   

Abstract

Adamantiades-Behçet disease is a well known clinical entity in the Mediterranean area. Signs and complications in these patients, arising from the macular area, are often overlooked for a prolonged period of time, because they are masked by the inflammatory signs of the anterior segment and/or the vitreous. Although blindness, in most cases, is the result of the optic disc atrophy, the macular alterations--as a sequelae of inflammation--are responsible for the low visual acuity. The authors in a retrospective clinical study of the last 100 consecutive cases of A-B disease, studied these macular alterations in detail. Their findings are also described in detail. Therapeutic modalities center around treatment with steroids, Cyclosporine A, and argon laser application. The results obtained from a long follow-up period are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2640221

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  3 in total

Review 1.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

2.  The Effect of Infliximab Therapy on Maculopathy in Behcet's Panuveitis: A Case Report.

Authors:  Ozlem G Sahin
Journal:  Case Rep Ophthalmol       Date:  2011-12-13

3.  [Ocular Behçet].

Authors:  Ahmed Alami; Mohamed Kriet; Karim Reda; Abdelkader Laktaoui; Abdelbaare Oubaaz
Journal:  Pan Afr Med J       Date:  2017-04-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.